[1.0 percent alcinonide ointment, a new topical corticosteroid preparation: clinico-therapeutic evaluation].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004485:Eczema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005260:Female; D006206:Halcinonide / Q000008:administration & dosage*; D006801:Humans; D008010:Lichen Planus / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010267:Parapsoriasis / Q000188:drug therapy; D010915:Pityriasis / Q000188:drug therapy; D011282:Pregnenediones / Q000008:administration & dosage*; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D009824:Ointments; D011282:Pregnenediones; D006206:Halcinonide
Alcinonide pomata 0.1% nuovo preparato topico corticosteroideo: valutazione clinico-terapeutica.